Keywords: Gray Matter, Visualization, thalamic morphometry, trigeminal neuralgia, biomarker
Motivation: The potential pathophysiologic mechanisms related to trigeminal neuralgia (TN) needed elucidation, and alternative biomarkers of TN needed to be identified.
Goal(s): To explore atrophy in specific subregions of the thalamus, which may contribute to the pathophysiology of TN.
Approach: We used vertex-based shape analysis to evaluate the differences in thalamus volume and shape in patients with TN and determine the location of regional thalamic atrophy.
Results: The analysis revealed distinct brain structural disparities between patients with TN exhibiting symptoms on the right and left sides. Compared with controls, patients with TN showed atrophy in specific subregions of the thalamus.
Impact: This study used an advanced deformation-based statistical shape analysis pipeline to investigate localized morphometric abnormalities in the thalamus, rather than relying on global volume measurements. It may help us understand the pathologic mechanism of trigeminal neuralgia.
References
1. Alper J, Seifert AC, Verma G et al. Leveraging high-resolution 7-tesla MRI to derive quantitative metrics for the trigeminal nerve and subnuclei of limbic structures in trigeminal neuralgia. J Headache Pain 2021;22:112.
2. Liu H, Hou H, Li F et al. Structural and functional brain changes in patients with classic trigeminal neuralgia: A combination of Voxel-Based morphometry and Resting-State functional MRI study. Front Neurosci 2022;16:930765.
3. Gambeta E, Chichorro JG, Zamponi GW. Trigeminal neuralgia: An overview from pathophysiology to pharmacological treatments. Mol Pain 2020;16:1744806920901890.
4. Boelens KJ, van Heese EM, Laansma MA et al. Structural assessment of thalamus morphology in brain disorders: A review and recommendation of thalamic nucleus segmentation and shape analysis. Neurosci Biobehav Rev 2021;131:466-478.
5. Shen S, Zheng H, Wang J et al. Gray matter volume reduction with different disease duration in trigeminal neuralgia. Neuroradiology 2022;64:301-311.
6. Mooney J, Erickson N, Pittman B et al. The use of MRI in preoperative Decision-Making for trigeminal neuralgia: A Single-Center study. World Neurosurg 2021;146:e651-e657.
7. Tang X, Luo Y, Chen Z et al. A Fully-Automated subcortical and ventricular shape generation pipeline preserving smoothness and anatomical topology. Front Neurosci 2018;12:321.
8. Ma J, Miller MI, Younes L. A bayesian generative model for surface template estimation. Int J Biomed Imaging 2010;2010.
9. Vaillant M, Glaunès J. Surface matching via currents. Inf Process Med Imaging 2005;19:381-92.
10. Tang X, Holland D, Dale AM et al. Shape abnormalities of subcortical and ventricular structures in mild cognitive impairment and Alzheimer's disease: Detecting, quantifying, and predicting. Hum Brain Mapp 2014;35:3701-25.
11. Nichols T, Hayasaka S. Controlling the familywise error rate in functional neuroimaging: A comparative review. Stat Methods Med Res 2003;12:419-46.
12. Vaculik MF, Noorani A, Hung PS et al. Selective hippocampal subfield volume reductions in classic trigeminal neuralgia. Neuroimage Clin 2019;23:101911.
13. Xu H, Zhang M, Wang Y. Shape deformations of the basal ganglia in patients with classical trigeminal neuralgia: A cross-sectional evaluation. Neurol Sci 2022;43:5007-5015.
14. Mo J, Zhang J, Hu W et al. Whole-brain morphological alterations associated with trigeminal neuralgia. J Headache Pain 2021;22:95.
15. Michels L, Koirala N, Groppa S et al. Structural brain network characteristics in patients with episodic and chronic migraine. J Headache Pain 2021;22:8.
16. Hebestreit JM, May A. Topiramate modulates trigeminal pain processing in thalamo-cortical networks in humans after single dose administration. Plos One 2017;12:e0184406.
17. Tu Y, Fu Z, Mao C et al. Distinct thalamocortical network dynamics are associated with the pathophysiology of chronic low back pain. Nat Commun 2020;11:3948.
SD, standard deviation; NA, not applicable; TN, trigeminal neuralgia; HCs, healthy controls
a p values were calculated with the analysis of variance (ANOVA)
b p value was obtained using a Pearson x2 test
c p values were calculated with two-tailed t tests
SD, standard deviation; NA, not applicable; TN, trigeminal neuralgia; HCs, healthy controls
p values were calculated with two-tailed t tests
SD, standard deviation; NA, not applicable; TN, trigeminal neuralgia; HCs, healthy controls
p values were calculated with two-tailed t tests
Figure 1 Shape analysis results for the bilateral thalamus in Right TN. Statistically significant group comparison results for the thalamus shape in each hemisphere as well as the corresponding subregion definitions. The color bar represents the per-centage of atrophy at a specific vertex in the disease group relative to the control group. The bottom panel illustrates the seven subregions of the bilateral thalamus. Two views (left: Lateral, right: Medial) are presented for each case.
Figure 2 Shape analysis results for the bilateral thalamus in Left TN. Statistically significant group comparison results for the thalamus shape in each hemisphere as well as the corresponding subregion definitions. The color bar represents the per-centage of atrophy at a specific vertex in the disease group relative to the control group. The bottom panel illustrates the seven subregions of the bilateral thalamus. Two views (left: Lateral, right: Medial) are presented for each case.